Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis.

导出 OA

翻译打印收藏纠错

作者： Rakhee,Bajaj ^[1] ; B Leticia,Rodriguez ^[2] ; William K,Russell ^[3] ; Amanda N,Warner ^[1] ; Lixia,Diao ^[4] ; Jing,Wang ^[4] ; Maria G,Raso ^[5] ; Wei,Lu ^[5] ; Khaja,Khan ^[5] ; Luisa S,Solis ^[5] ; Harsh,Batra ^[5] ; Ximing,Tang ^[5] ; Jared F,Fradette ^[1] ; Samrat T,Kundu ^[2] ; Don L,Gibbons ^[6]

作者单位： Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030, USA. ^[1] Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. ^[2] Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. ^[3] Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ^[4] Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. ^[5] Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: dlgibbon@mdanderson.org. ^[6]